News
Genentech, a member of the Roche Group, will create 400 jobs with a new biotechnology facility in Holly Springs, Wake County, ...
GenAI is netting organizations big efficiencies and potential cost savings, but many are still reluctant to fully release the ...
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Macro Vargas of Lowell is gaining lab skills through Bioversity's Biotech Career Foundations certificate program at UMass ...
The genome structure — how genes are organized within DNA sequences in an organism — is fundamental to the processes and functions of organisms. A ...
BlackRock highlighted that the trade conflict between the US and China continues to cause major economic disruptions.
17h
Indulgexpress on MSNSocial media’s growing influence on cosmeceuticalsIf you’ve come across the phrase— looking like a ‘glazed donut before bed’, chances are you’ve stumbled upon one of Hailey ...
17h
Bangkok Post on MSNWhy OECD membership mattersIn a highly fragmented world, Thailand's accession to the Organisation for Economic Cooperation Development (OECD) is more than just a diplomatic gesture -- it marks a transformative opportunity to ...
a. Vaxart is at risk of being delisted from Nasdaq since the Company’s share price is not in compliance with their minimum $1.00 bid price requirement. A reverse split of the Company’s common stock ...
President Donald Trump on Monday signed an executive order asking drugmakers to voluntarily reduce the prices of key ...
Metsera, Inc.: Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress
MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, is in three ongoing VESPER Phase 2b trials, with data from VESPER-1 expected in mid-2025 MET-233i, a monthly, ultra-long ac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results